TGen develops quality-control test for detecting cancer in blood

(The Translational Genomics Research Institute) There is vast potential in precision-medicine methods of both detecting and monitoring disease by looking for indications of cancer mutations in cell-free DNA (cfDNA), found floating in the blood. To help ensure the quality of these molecular biomarkers, a scientific team led by the Translational Genomics Research Institute (TGen) has devised a rapid test -- a droplet digital PCR (ddPCR) assay -- so these samples can be used to help determine the presence and progression of disease.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news